(BFW) Rolls-Royce Says No Longer in Talks With Waertsilae

+------------------------------------------------------------------------------+

PRN 01/09 07:00 ROLLS-ROYCE HOLDINGS PLC: Statement re Press Comment BFW 01/09 07:03 *ROLLS-ROYCE SAYS WÄRTSILÄ TALKS ARE NO LONGER CONTINUING BFW 01/09 07:02 *ROLLS-ROYCE CONFIRMS HAD BEEN IN PRELIM. TALKS WITH WAERTSILÄ BN 01/09 07:02 *ROLLS-ROYCE SAYS WÄRTSILÄ TALKS ARE NO LONGER CONTINUING BN 01/09 07:01 *ROLLS-ROYCE CONFIRMS HAS BEEN IN PRELIM. TALKS WITH WAERTSILÄ BN 01/09 07:00 *ROLLS-ROYCE HOLDINGS STATEMENT RE PRESS COMMENT

+------------------------------------------------------------------------------+

Rolls-Royce Says No Longer in Talks With Waertsilae 2014-01-09 07:06:23.774 GMT

By Gaurav Panchal Jan. 9 (Bloomberg) -- Responds to press speculation, confirms that it has been in preliminary talks with Waertsilae regarding a possible offer for the company. * Says those discussions are no longer continuing * Statement:{NSN MZ4GSM3MMTC0 <GO>} * Jan. 8: Rolls-Royce Said to Explore Offer for Waertsilae’s Marine Unit {NSN MZ3KGX6K50YD <go>}

Link to Company News:{RR/ LN <Equity> CN <GO>} Link to Company News:{WRT1V FH <Equity> CN <GO>}

For Related News and Information: First Word scrolling panel: {FIRST<GO>} First Word newswire: {NH BFW<GO>}

To contact the editor responsible for this story: Gaurav Panchal at +44-20-7392-0511 or gpanchal2@bloomberg.net

>>> Brokers Upgrades & Downgrades - 9th of Jan 2014

>>> Up
*ALCATEL RESUMED OVERWEIGHT AT MORGAN STANLEY, PT EU3.7
*AXEL SPRINGER RAISED TO EQUALWEIGHT AT MORGAN STANLEY
*BARRATT RAISED TO BUY AT CITI
*CRH PLC RAISED TO BUY VS NEUTRAL AT UBS
*EDP RAISED TO HOLD VS REDUCE AT KEPLER CHEUVREUX
*ESSILOR RAISED TO BUY FROM HOLD AT JEFFERIES
*FRESENIUS MEDICAL CARE RAISED TO NEUTRAL AT JPMORGAN
*GENEL ENERGY RAISED TO OVERWEIGHT VS NEUTRAL AT HSBC
*HERMES RAISED TO BUY VS NEUTRAL AT BOFAML
*NORSK HYDRO RAISED TO BUY FROM HOLD AT NORDEA
*TULLOW OIL RAISED TO OVERWEIGHT VS NEUTRAL AT HSBC

>>> Down
*ALCATEL-LUCENT CUT TO HOLD VS BUY AT DEUTSCHE BANK
*ARM HOLDINGS CUT TO HOLD VS BUY AT DEUTSCHE BANK
*BRITISH LAND RAISED TO OUTPERFORM VS NEUTRAL AT EXANE
*CSR CUT TO EQUALWEIGHT VS OVERWEIGHT AT MORGAN STANLEY
*DNO CUT TO UNDERWEIGHT VS NEUTRAL AT HSBC
*ECONOCOM CUT TO HOLD FROM BUY AT ING
*EDENRED CUT TO UNDERPERFORM VS NEUTRAL AT BOFAML
*FERRAGAMO CUT TO REDUCE VS HOLD AT KEPLER CHEUVREUX
*HIKMA CUT TO NEUTRAL VS BUY AT BOFAML
*HUGO BOSS CUT TO UNDERPERFORM VS NEUTRAL AT BOFAML
*ICADE CUT TO NEUTRAL VS OUTPERFORM AT EXANE
*INTERCONTINENTAL HOTELS CUT TO NEUTRAL VS BUY AT BOFAML
*KERING CUT TO UNDERPERFORM VS BUY AT BOFAML
*LADBROKES CUT TO UNDERWEIGHT VS EQUALWEIGHT AT BARCLAYS
*LINDT & SPRUENGLI CUT TO HOLD VS BUY AT BERENBERG
*LUNDIN PETROLEUM CUT TO NEUTRAL VS OUTPERFORM AT CREDIT SUISSE
*MEDIASET ESPANA CUT TO UNDERWEIGHT AT MORGAN STANLEY
*MEGAFON CUT TO NEUTRAL VS OUTPERFORM AT CREDIT SUISSE
*MTS CUT TO UNDERPERFORM VS OUTPERFORM AT CREDIT SUISSE
*ORANGE CUT TO UNDERPERFORM AT CREDIT SUISSE, PT EU8.50
*PENNON CUT TO NEUTRAL VS OVERWEIGHT AT HSBC
*PRADA CUT TO NEUTRAL VS BUY AT BOFAML
*REDROW CUT TO NEUTRAL AT CITI
*RTL CUT TO NEUTRAL VS OVERWEIGHT AT JPMORGAN
*STMICROELECTRONICS CUT TO SELL AT DEUTSCHE BANK
*UNILEVER CUT TO HOLD VS BUY AT BERENBERG
*VIMPELCOM CUT TO UNDERPERFORM VS NEUTRAL AT CREDIT SUISSE
*WILLIAM HILL CUT TO EQUALWEIGHT VS OVERWEIGHT AT BARCLAYS

>>> PT Change
*Amplifon PT Raised to EU4.15 vs EU4 at Bernstein
*Centrica PT Cut to 312p vs 327p at Raymond James
*DECEUNINCK PT RAISED TO EU1.85 FROM EU1.35 AT ING
*Edenred PT Cut to EU26 vs EU28 at Raymond James
*TENARIS ADR PT CUT TO $50.5 VS $52 AT BOFAML; KEPT AT NEUTRAL
*UBS PT Raised to CHF19 vs CHF18 at Mediobanca; Kept at Neutral

>>> Initiation
*ASM INTERNATIONAL RATED NEW BUY AT ING, PT EU31
*BE SEMICONDUCTOR INDUSTRIES RATED NEW BUY AT ING, PT EU14
*NEXANS RATED NEW EQUALWEIGHT AT BARCLAYS; PT EU38
*Prysmian PT Raised to EU22.5 vs EU16 at Barclays

>>> Calls
>>Stock
*CRH, WIENERBERGER ADDED TO MOST PREFERRED BUILDING SHRS AT UBS {NSN MZ4G5N6JIJUZ <go>}
*CRH REMOVED FROM LEAST PREFERRED BUILDING SHRS AT UBS {NSN MZ4G5N6JIJUZ <go>}
*WOLSELEY REMOVED FROM MOST PREFERRED BUILDING SHRS AT UBS

>>> What to look at today - 9th of Jan 2014

US Market was mixed with S&P Lower and Nasdq higher, Materials, Financials & Tech the only sectors up, Semis higher on the back of MU Numbers (+9,9%)...Energy was the weakest sector on back of crude oil lower by 1,4%...Volume was the highest since the 20th of dec @ 742mil shares...VIX @ 12,88 -0,31%...SKEW @129,10 -2,19%...Brazil +0,29%...BBY misses by $0.03, reports revs in-line; lowers Q4 EPS guidance below consensus...Macy's up 5% on guidance and cost reduction initiatives/restructuring... KSS, JWN, DDS, SHLD on radar...US retailers BBBY and ZUMZ down sharply in extended session after lowering guidance...China inflation slows drastically - CPI fall 0.5pts to a 7-month lows. Food component of the CPI falls nearly 2pts to 4.1%. China trade data will be released in tomorrow's session...Nikkei -1.50%...Shanghai -0.79%

Eur$ 1.3595 S&P Fut +0.01% European Fut +0.10%

Keep an eye on :
- ALV GY : Allianz CFO Wemmer Calls for End to Banker Bashing: Handelsblatt
- AKE FP : Arkema Cuts FY 2013 Ebitda Forecast to Around EU900m vs EU920m
- AZN LN : Bristol/AstraZeneca Wins FDA Approval for Diabetes Drug Farxiga
- BGN IM : Banca Generali 2013 Total Net Inflows EU2.26b, Up 40%
- BING GY : Actavis Gets Approval for Generic Copy of Boehringer's Micardis
- BMW GY : BMW’s Rolls-Royce Division Says 2013 Sales Exceeded 3,600 Cars
- BN FP : Fonterra Will Vigorously Defend Proceedings Brought by Danone
- CLS1 GY : McKesson Raises Offer for Celesio to EU23.50-Shr, Reuters Says
- DTE GY : T-Mobile Says Added More Than 1.6m Subs in 4Q
- ERF FP : Eurofins to Buy Merck KGaA's Discovery and Development Business
- F IM : Fiat Debt to Restrict Restructuring or Growth Plans, Nomura Says
- FUM1V FH : Fortum is selling its Tohkoja wind power project in Kalajoki, (Finland) to wpd Europe.
- GET FP : U.K. Eurotunnel Passengers to Be Able to Use Mobile Phones
- GRG LN : Greggs Sees Yr Results In Line With Previous Forecasts
- GSK LN : GSK Gains Accelerated FDA Approval on Mekinist and Tafinlar
- GSZ FP : GDF’s Mestrallet Aims to Hire 20,000 People by 2015: Challenges
- GWI1 GY : Gerry Weber 4Q Retail Rev. Up 22%; Good 4Q Trend Carried Over
- HAV FP : Havas Says Yannick Bollore to Replace Jones as CEO, Jones will be pursue other opportunities
- HAV FP : Havas’s Bollore Says On Track to Meet 2013 Budget
- INGA NA : ING Says Pension Pact With Unions to Cut Equity Volatility
- LEG GY : Leg Immobilien Buys EU26.m Portfolio, Raises 2014 FFO I Outlook
- MOR GY : Morphosys seeks acquisitions opportunities or partenership, reason of las sept cap increase of €84m
- NOVN VX : Transgene to Move Novartis Drug Candidate Into Advanced Tests, {NSN MZ3QTN6TTDS1 <go>}
- NOVN VX : Novartis Said in Talks With Merck on $5b Unit Swap
- NOVN VX : Novartis Sued by U.S. States on Alleged Kickbacks: Reuters
- ORA FP : Orange to Announce Higher 4G Tariffs at Start Feb., Ernotte Says
- PC IM : Pirelli CEO to Resign 2017, Frankfurter Allgemeine Zeitung Says
- RBI AV : Raiffeisen Sees Capital Increase EU2b-EU2.25b; No Hungary Sale
- RBS LN : RBS Considering Cutting Thousands More Jobs, Sky Reports
- RR/ LN : Rolls-Royce Said to Explore Offer for Waertsilae's Marine Unit
- SAP GY : SAP Confirms Robert Calderoni Has Resigned, in charge of Clouds Ops.
- STAN LN : Standard Chartered Sees Slowing Hong Kong Loan Growth: HKET
- SRN IM : Monte Paschi Sells 5.7% Stake in Sorin for EU2.05/Shr
- TGS NO : TGS Sees 2013 Net Revenue About $882m Vs Guidance $810m to $870m
- VOD LN : Vodafone, Orange to Integrate Spain Networks, Expansion Says
- VOW3 GY : Bentley's Chinese sales slip amid crackdown on ostentation

>>> Asian Update

Asian Market Update: China inflation slows while Australia retail sales surprise higher; BOK on hold as expected

***Observations/Insights*** - US retailers BBBY and ZUMZ down sharply in extended session after lowering guidance. - China inflation slows drastically - CPI fall 0.5pts to a 7-month lows. Food component of the CPI falls nearly 2pts to 4.1%. China trade data will be released in tomorrow's session. - Australia economic data coming in mixed/positive; Despite the soft imports component of the most recent Australia trade figures, retail sales outperform against estimates with a 5th consecutive month of increase. - Bank of Korea leaves rates on hold for the 8th consecutive month as expected. BOK Gov Kim maintains projections for 2014 GDP at 3.8% and also targets 2015 GDP at 4.0%. BOK also reiterated inflation will rise gradually, but remain low for time being.

***Economic Data*** - (CN) CHINA DEC CONSUMER PRICE INDEX (CPI) M/M: +0.3% V -0.1% PRIOR; Y/Y: 2.5% V 2.7%E (7-month low) - (CN) CHINA DEC PRODUCER PRICE INDEX (PPI) Y/Y: -1.4% V -1.3%E (22nd month of decline) - (AU) AUSTRALIA NOV BUILDING APPROVALS M/M: -1.5% V -1.0%E (2nd consecutive decline); Y/Y: 22.2% V 21.1%E - (AU) AUSTRALIA NOV RETAIL SALES M/M: 0.7% V 0.4%E (5th consecutive increase) - (NZ) NEW ZEALAND DEC ANZ COMMODITY PRICE M/M: +1.0% V -0.3% PRIOR - (NZ) NEW ZEALAND NOV BUILDING PERMITS M/M: 11.1% V 0.3% PRIOR (largest increase in 7 months) - (KR) BANK OF KOREA (BOK) LEAVES 7-DAY REPO RATE UNCHANGED AT 2.50% (AS EXPECTED); (8TH STRAIGHT PAUSE) - (JP) JAPAN DEC TOKYO AVERAGE OFFICE VACANCIES: 7.3 V 7.5 PRIOR - (TH) THAILAND DEC CONSUMER CONFIDENCE: 73.4 V 75.0 PRIOR (lowest level in 2-yrs) - (MY) MALAYSIA NOV INDUSTRIAL PRODUCTION: 4.4% V 2.9%E; MANUFACTURING SALES VALUE Y/Y: 4.4% V 1.9% PRIOR

***Fixed Income/Commodities/Currencies*** - JGB: Japan Ministry of Finance (MOF) sells ¥299.5B in 0.1% CPI-linked 10-yr JGB auction, bid-to-cover ratio 2.87x v 3.74x prior - (CN) Daily Shibor fixings: O/N: 2.7940% v 2.8300% prior (12th consecutive decline, lowest since May 15th); 1-week: 4.0200% v 4.1260% prior (6th consecutive decline) - (CN) PBoC won't conduct open market operations (OMO) in today's session (5th consecutive session of halted operations); Zero net position this week v drained CNY29B in prior week - USD/CNY: (CN) PBoC sets yuan mid point at 6.1109 v 6.1079 prior (weakest Yuan setting since Dec 25th) - GLD: SPDR Gold Trust ETF daily holdings fall 1.5 tonnes to 793.1 tonnes (lowest since Jan 2009)

- AUD initially rallied on higher retail sales but met some resistance in the $0.89 handle, selling down below $0.8870 in the afternoon session. Remaining dollar majors were little changed - EUR/USD was modestly firmer above $1.3590 ahead of the ECB decision, while USD/JPY pair is unable to sustain the momentum of 3 consecutive rising sessions to breach the ¥105 handle. NZD/USD was down about 20 pips below $0.8250, while KRW was stronger following the BOK decision - USD/KRW fell below KRW1,065 - second session of losses after 3 days of gains.

***Speakers/Political/In the Papers*** - (CN) Moody's analyst: global environment is the best in years; China economy to keep pace in 2014 - Shanghai Daily - (CN) China Iron and Steel Association (CISA): China average daily crude steel output 1.96M tonnes in late Dec, -2.7% from previous 10 days - financial press - (CN) China Guangdong Province reports 1 new case of H7N9 bird flu; Hong Kong confirms 1 new case of H7N9 bird flu - press - (JP) BOJ board member Shirai: BOJ may ease more 'without hesitation' if necessary; 2% inflation target is major transition in Japan policy; Sees limited upward pressure on JGB yields so far. - (IN) Moody's: India govt debt structure mitigates macro economic imbalances

***Equities*** Market Snapshot (as of 04:30 GMT): - Nikkei225 -1.5%, S&P/ASX -0.2%, Kospi -0.1%, Shanghai Composite +0.4%, Hang Seng -0.1%, Mar S&P500 flat at 1,832, Feb gold +0.1% at $1,227, Feb crude oil +0.7% at $92.58 /brl

US markets: - M: Affirms FY13 EPS guidance; Guides initial FY14 $4.40-4.50 v $4.34e, SSS +2.5-3.0%; Outlines Cost Reduction Initiatives (laying off 2500 workers, 1.4% of workforce) to Support Continued Profitable Sales Growth; savings expected at $100M per year beginning in 2014; +5.3% afterhours - GPN: Reports Q2 $1.02 v $1.02e, R$634.1M v $624Me; +5.1% afterhours - AGU: Announces strategic review of Agrium Advanced Technologies; to transition to two Strategic Business units, Wholesale and Retail in Q1; +2.5% afterhours - RT: Reports Q2 -$0.43 (adj) v -$0.24e, R$276.2M v $271Me; +2.4% afterhours - GG: Reports Q4 gold production 767.7K oz, +11% y/y; Guides 2014 gold production 3.0-3.15M oz, +13-18% y/y; +0.2% afterhours

- AAPL: Apple and Samsung agree to mediation in US patent dispute on or before Fed 19th, with CEOs present - financial press cites court filing; flat afterhours

- DISH: Said to have pulled its bid for Lightsquared; flat afterhours - EXFO: Reports Q1 -$0.01 v +$0.02e, R$56M v $61Me (only 2 ests); saw lower bookings from key customers; -4.8% afterhours - BBBY: Reports Q3 $1.12 v $1.15e, R$2.87B v $2.89Be; Lowers FY13 guidance; Lowers Q4 SSS guidance to 2-4% v 3.5-5.5% prior forecast; FY13 SSS +2.5-3.1% - conf call; -8.4% afterhours - ZUMZ: Reports Dec SSS -2.4% v +1.7%e; Lowers Q4 guidance to $0.56-0.59 v $0.69e; Rev to $226-229M v $234Me (guided R$230-237M prior); -8.5% afterhours

Notable movers by sector: - Consumer discretionary: Qantas QAN.AU +1.6% (Moody's ratings action); Huayi Brothers Media 300027.CN +3.7%, Zhejiang Huace Film & TV 300133.CN +4.8%, China Television Media 600088.CN +2.6% (continued momentum on China box office results) - Industrials: Beijing Jiaxun Feihong Electrical 300213.CN +3.5% (FY13 guidance) - Energy: Offshore Oil Engineering 600583.CN +9.9% (FY13 guidance) - Financials: Agile Property Holdings 3383.HK +2.5% (FY13 guidance); Road King Infrastructure 1098.HK +1.7% (2013 contracted sales); Poly Real Estate 600048.CN +2.5% (Dec contracted sales) - Technology: Shenzhen Changfang Light Emitting Diode Lighting 300301.CN +2.3% (awarded order); Sony 6758.JP +4.0% (CEO comments); Canon -2.0% (speculation on FY13 result) - Materials: Gansu Gangtai Holding Group 600687.CN +8.1% (FY13 guidance) - Healthcare: Guilin Layn Natural Ingredients 002166.CN +2.3%, Beijing Tiantan Biological Products 1.2%, Shenzhen Neptunus Bioengineering +2.1% (1 new case of H7N9) - Utilities: TEPCO 9501.JP -1.0% (Dutch pension fund sells stake; regulator may submit report on Fukushima)

WSJ : Dish Pulling Its Bid for LightSquared

Dish Pulling Its Bid for LightSquared Letter of Termination of Bid Expected to Be Disclosed as Soon as Thursday Dish Network Corp. is officially pulling its bid for LightSquared Inc., the telecommunications firm in bankruptcy that has wireless spectrum Dish has been coveting, according to people familiar with the matter. The reversal, after Dish last year put in a bid for $2.2 billion, marks the latest twist in the high-profile case, in which LightSquared has hit a number of speed bumps in its effort to emerge from bankruptcy. Dish is expected to disclose its letter of termination of the bid as soon as Thursday morning, one of the people said. Dish's plans have already met resistance from LightSquared lenders, who want to go forward with the Dish deal. On Tuesday, a lawyer for the lenders said in court he believes Dish has breached a contract by refusing to go through with the purchase of LightSquared's wireless spectrum. The lenders, who own nearly $2 billion in LightSquared bank debt, have proposed a restructuring plan based on Dish's bid. Rachel Strickland, a lawyer for Dish and its chairman, Charlie Ergen, said in court Tuesday she doesn't think Dish breached the contract. On Tuesday, the parties said in court Dish hadn't formally terminated the agreement to buy LightSquared's assets. Judge Shelley C. Chapman of U.S. Bankruptcy Court in Manhattan was to consider approving a reorganization plan for LightSquared based on the Dish bid later this week, as well as a plan to sell a smaller part of the spectrum to LightSquared creditors Mast Capital Management and U.S. Bancorp. Those proposals are competing with a separate one from LightSquared, which Judge Chapman is set to consider later this month. LightSquared has opposed the Dish bid and said that its $4 billion restructuring proposal—led by Fortress Investment Group LLC—is actually better than the Dish sale and smaller sale. Harbinger Capital Partners, started by financier Philip Falcone, is LightSquared's original backer. Spectrum refers to the limited pockets of airwaves that mobile phone and Internet companies use. Both the Dish and LightSquared plans would pay off the holders of more than $1.8 billion in LightSquared bank debt, a group that includes hedge funds and an investment entity wholly owned by Mr. Ergen. Meanwhile, as of Wednesday evening, one of the people familiar with the matter said, related litigation was expected to move ahead in court on Thursday though the situation remained fluid. That matter concerns accusations by LightSquared that the investment entity controlled by Dish's Mr. Ergen fraudulently purchased more than $1 billion in LightSquared debt. LightSquared has said the purchases violate a provision of its credit agreement prohibiting competitors from buying its debt. Mr. Ergen has said he bought the debt as an individual, and the investment vehicle isn't affiliated with Dish. A representative for Dish has called LightSquared's complaint "a desperate measure." Write to Emily Glazer at emily.glazer@wsj.com

>>>US After Hours

After Hours Summary: MG +6.5%, GPN +5.1%, M +5.0%, CALX -10.9%, MATR -9.4%, BBBY -8.3%, ZUMZ -6.4% following earnings/guidance After Hours Gainers:

Companies trading higher in after hours in reaction to earnings: MG +6.5%, GPN +5.1%, M +5.0%, EHTH +2.3%, RT +0.5%

Companies trading higher in after hours in reaction to news: SQNM +10.6% (announced issuance of European patent for novel methods of detecting fetal aneuploidy), M +5.0% (co will lay off 2500 employees and close 5 stores; co also issued upside guidance for FY15), TGB +4.2% (announced 35% increase in annual copper production), AGU +2.8% (announces strategic review of Agrium Advanced Technologies: to transition to two Strategic Business units), ACT +2.8% (generic version of Micardis received FDA approval), JRN +1.3% (announced Journal Broadcast Group reached retransmission agreements with AT&T, Cable One, and Cox)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings: CALX -10.9%, MATR -9.4%, BBBY -8.3%, ZUMZ -6.4%, VOXX -5.1%, EXFO -4.8%, QDEL -4.0%, ROVI -3.3%, WDFC -1.1%

Companies trading lower in after hours in reaction to news: AEZS -16.4% (announced proposed public offering of common shares and warrants), PLUG -12.8% (move attributed to cautious blog mention), EXFO -4.8% (renewed normal course issuer bid, co also reported earnings), BXMT -2.4% (announced public offering of 8.5 mln class A common stock), EGY -2.0% (provided operations update)

WSJ : Astra Held to Account in Diabetes Deal

Astra Held to Account in Diabetes Deal

Investors Should Ask if They Are Getting All the Information Needed From the Core Earnings Number, Thanks to Diabetes Deal's Treatment

AstraZeneca AZN.LN -0.36% has started 2014 with another deal, striking a partnership Wednesday to develop cancer treatments in one of the most promising areas of oncology.

But the U.K. pharmaceutical company is still courting controversy over how it plans to account for its last transaction, a $4.3 billion purchase of Bristol-Myers Squibb's BMY +1.64% share in their diabetes alliance.

Under the terms of that deal, announced in December, Astra will pay $2.7 billion to Bristol upfront, plus $1.6 billion in payments based on regulatory, drug-launch and sales milestones, and asset transfers. Astra will also pay Bristol sizable royalties on sales of diabetes drugs through 2025. In total, according to Astra, the risk-adjusted present value of royalties and other contingent payments comes to $5.6 billion, or about two-thirds of the deal's value.

Here's the rub: Those payments won't show up in what Astra calls its "core earnings." Those are different from the earnings the company reports under international accounting rules and are adjusted for things like restructuring costs or the amortization of intangible assets.

While investors track the core figure, they have to keep in mind that it is a subjective, pro-forma measure that may not always be the best gauge of profit. That is especially important when considering the diabetes deal.

Under international accounting rules, Astra is obliged effectively to log the deal's total value on its balance sheet. The intangible assets, also about $5.6 billion, will be amortized, or reduced in value, over time. That cuts into reported earnings.

Astra excludes that from its calculation of core earnings. It reckons it is effectively financing the deal through payments to Bristol over the next 12 years, rather than spending $8.3 billion upfront, which mostly wouldn't hurt earnings.

But investors have questioned this presentation. Analysts at Credit Suisse, CSGN.VX +0.49% who first flagged the issue, referred to it as "aggressive."

In particular, the payment of cash royalties to Bristol each year won't hit Astra's core earnings, even though in some ways they are akin to a cost of selling goods. And the royalties are "significant," notes Deutsche Bank DBK.XE +2.00% analyst Mark Clark, accounting for an estimated 3% of core pretax profit in 2014, rising to 9% in 2018.

Astra's approach may also raise corporate-governance questions. One of its management-incentive plans has a payout hurdle that from 2013 onward will be based on its core earnings per share staying above 1.5 times its dividend per share. By excluding the deal costs from this core figure, management has a lower bar to clear.

In fairness, tinkering with the definition of core earnings in such cases could potentially create perverse incentives for management to undertake riskier deals with more paid upfront. And Astra isn't alone in treating such royalty payments this way.

But Astra is facing a crucial period of falling sales through 2017 as its blockbuster statin drug Crestor loses patent protection. Investors should ask whether they are getting the right picture of the costs and the benefits of Astra's bet on diabetes in coming years.

WSJ : Key Passages in Fed Minutes: Consensus on QE, Focus on Bubbles

Key Passages in Fed Minutes: Consensus on QE, Focus on Bubbles

By JON HILSENRATH

Federal Reserve officials were largely in agreement on the decision to begin winding down an $85 billion-per-month bond-buying program. As they looked to 2014, they began to focus more on the risk of bubbles and financial excess.


The Federal Reserve building in Washington. Associated Press
Here is a look at key passages in the minutes of the Dec. 17-18 meeting of the Fed’s policy committee, released Wednesday:

WIDESPREAD AGREEMENT ON WINDING DOWN BOND BUYING

Participants generally anticipated that the improvement in labor market conditions would continue, and most had become more confident in that outlook. Against this backdrop, most participants saw a reduction in the pace of purchases as appropriate at this meeting and consistent with the Committee’s previous policy communications.

FED WANTED TO TAKE CAUTIOUS APPROACH TO WINDING DOWN BOND BUYING

Some … expressed concern about the potential for an unintended tightening of financial conditions if a reduction in the pace of asset purchases was misinterpreted as signaling that the Committee was likely to withdraw policy accommodation more quickly than had been anticipated. As a consequence, many members judged that the Committee should proceed cautiously in taking its first action to reduce the pace of asset purchases and should indicate that further reductions would be undertaken in measured steps.

SOME OFFICIALS WANT TO PLACE MORE WEIGHT ON BUBBLES

Several [Fed officials] commented on the rise in forward price-to-earnings ratios for some small cap stocks, the increased level of equity repurchases, or the rise in margin credit. One pointed to the increase in issuance of leveraged loans this year and the apparent decline in the average quality of such loans. A couple of participants offered views on the role of financial stability in monetary policy decision making more broadly. One proposed that the Committee analyze more explicitly the potential consequences of specific risks to the financial system for its dual-mandate objectives and take account of the possible effects of monetary policy on such risks in its assessment of appropriate policy. Another suggested that the importance of financial stability considerations in the Committee’s deliberations would likely increase over time as progress is made toward the Committee’s objectives, and that such considerations should be incorporated into forward guidance for the federal funds rate and asset purchases.

STAFF FINANCIAL STABILITY REVIEW: MOSTLY GREEN LIGHTS

The staff’s periodic report on potential risks to financial stability concluded that the vulnerability of the financial system to adverse shocks remained at moderate levels overall. Relatively strong capital profiles of large domestic banking firms, low levels and moderate growth of aggregate credit in the nonfinancial sectors, and some reduction in reliance on short-term wholesale funding across the financial sector were seen as factors supporting financial stability in the current environment. Valuations in most asset markets seemed broadly in line with historical norms. However, the staff report noted that the complexity and interconnectedness of large financial institutions, along with some apparent increases in investor appetite for higher-yielding assets and associated pressures on underwriting standards remained potential sources of risk to the financial system.

LITTLE INTEREST AT FED MEETING IN CHANGING FORMAL THRESHOLDS FOR RAISING INTEREST RATES

Participants debated the advantages and disadvantages of lowering the unemployment rate threshold provided in the forward guidance. In the view of the few participants who advocated such a change, a lower threshold would be a clear signal of the Committee’s intentions and was an appropriate adjustment in light of recent labor market and inflation trends. In contrast, a few others expressed concern that any change in the threshold might be confusing and could undermine the credibility of the Committee’s forward guidance. Most were inclined to retain the current thresholds for the unemployment and inflation rates.

FED STAFF SEES STRONGER DOLLAR, MORE OPTIMISTIC ABOUT GROWTH:

The [staff] forecast for growth in real gross domestic product (GDP) in the second half of this year was revised up a little from the one prepared for the previous meeting, as the recent information on private domestic final demand—particularly consumer spending—was somewhat better, on balance, than the staff had anticipated. The staff’s medium term forecast for real GDP growth was also revised up slightly, reflecting a small reduction in fiscal restraint from the recent federal budget agreement, which the staff assumed would be enacted; a lower anticipated trajectory for longer-term interest rates; and higher paths for equity values and home prices. Those factors, in total, more than offset a higher path for the foreign exchange value of the dollar. The staff continued to project that real GDP would expand more quickly over the next few years than it has this year and would rise significantly faster than the growth rate of potential output.

>>> US Close Dow -0,41% S&P -0,06% Nasdaq +0,30%

Closing Market Summary: Stocks End Mixed

The major averages ended the Wednesday session on a mixed note as the Nasdaq added 0.3%, the Dow shed 0.4% while the S&P 500 essentially split the difference, ending flat.

Equity indices began the session on a lower note, but the Nasdaq and S&P 500 staged swift rallies to new highs. The two indices hovered near their best levels of the session for the remainder of the trading day, but tested their lows during the final hour. For its part, the Dow Jones Industrial Average was unable to eclipse its morning high as 20 of its 30 components registered losses.

Prior to the open, it was reported that private sector employment increased by 238,000 in December while the consensus expected a reading of 203,000. The strong report was received by the bond market as a sign suggesting the Fed could engage in additional tapering sooner rather than later. On that note, the December FOMC minutes revealed that some officials saw "waning benefits" from monthly bond purchases. Furthermore, some members wanted to see a quicker end to the asset purchasing program. Treasuries settled near their lows with the 10-yr yield up five basis points at 3.00%.

Six of ten sectors ended in the red with rate-sensitive consumer staples (-0.7%), telecom services (-1.7%), and utilities (-0.6%) leading the slide as higher yields weighed. The fourth defensive sector—health care (+0.9%)—finished in the lead with help from biotechnology. The iShares Nasdaq Biotechnology ETF (IBB 231.58, +4.65) jumped 2.1%, also contributing to the outperformance of the Nasdaq.

Outside of health care, financials (+0.3%), materials (+0.6%), and technology (+0.1%) were the only other advancers. The materials sector received support from chemical producers after Monsanto (MON 115.23, +2.12) beat on earnings and revenue.

Elsewhere, the technology sector ended flat with its relative strength providing a boost to the Nasdaq. Chipmakers rallied broadly after Micron (MU 23.86, +2.13) beat on earnings and revenue. Micron soared 9.9% while the broader PHLX Semiconductor Index rose 1.6%.

On the downside, the energy sector (-0.7%) was the weakest cyclical group as crude oil fell 1.4% to $92.32/bbl.

Today's session saw the most activity since December 20 as 742 million shares changed hands on the floor of the New York Stock Exchange.

Tomorrow, the December Challenger Job Cuts report will be released at 7:30 ET while weekly initial claims will be reported at 8:30 ET.
Nasdaq -0.3% YTD
Russell 2000 -0.4% YTD
S&P 500 -0.6% YTD
DJIA -0.7% YTD